Literature DB >> 23959161

Levodopa inhibits habit-learning in Parkinson’s disease.

Hannah Fuhrer, Andreas Kupsch, Thomas D Hälbig, Ute A Kopp, Peter Scherer, Doreen Gruber.   

Abstract

Mixed dopaminergic medication, comprising dopamine agonists and levodopa, may affect habit-learning in patients with Parkinson’s disease (PD). However, the specific impact of levodopa on this effect is unknown. We assessed habit-learning in 20 non-demented PD-patients both with and without levodopa. We observed intact habit-learning in PD-patients OFF-medication. In contrast, the administration of 200 mg of levodopa impaired habit-learning. We conclude that potential deficits in habit-learning in PD may be attributed to the intake of levodopa.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23959161     DOI: 10.1007/s00702-013-1081-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  11 in total

Review 1.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Authors:  G L Defer; H Widner; R M Marié; P Rémy; M Levivier
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

Review 2.  Cognitive deficits in Parkinson's disease.

Authors:  B Dubois; B Pillon
Journal:  J Neurol       Date:  1997-01       Impact factor: 4.849

3.  Levodopa and the progression of Parkinson's disease.

Authors:  Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony Lang; C Warren Olanow; Caroline Tanner; Kenneth Marek
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

Review 4.  Inverted-U-shaped dopamine actions on human working memory and cognitive control.

Authors:  Roshan Cools; Mark D'Esposito
Journal:  Biol Psychiatry       Date:  2011-05-04       Impact factor: 13.382

5.  By carrot or by stick: cognitive reinforcement learning in parkinsonism.

Authors:  Michael J Frank; Lauren C Seeberger; Randall C O'reilly
Journal:  Science       Date:  2004-11-04       Impact factor: 47.728

6.  Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism.

Authors:  Michael J Frank
Journal:  J Cogn Neurosci       Date:  2005-01       Impact factor: 3.225

7.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.

Authors:  R Cools; R A Barker; B J Sahakian; T W Robbins
Journal:  Cereb Cortex       Date:  2001-12       Impact factor: 5.357

8.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

9.  Medication impairs probabilistic classification learning in Parkinson's disease.

Authors:  Marjan Jahanshahi; Leonora Wilkinson; Harpreet Gahir; Angeline Dharmaindra; Angeline Dharmarinda; Angeline Dharminda; David A Lagnado
Journal:  Neuropsychologia       Date:  2009-12-16       Impact factor: 3.139

10.  Subthalamic stimulation differentially modulates declarative and nondeclarative memory.

Authors:  Thomas D Hälbig; Doreen Gruber; Ute A Kopp; Peter Scherer; Gerd-Helge Schneider; Thomas Trottenberg; Guy Arnold; Andreas Kupsch
Journal:  Neuroreport       Date:  2004-03-01       Impact factor: 1.837

View more
  4 in total

1.  Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.

Authors:  Bernd Leplow; Maria Sepke; Robby Schönfeld; Johannes Pohl; Henriette Oelsner; Lea Latzko; Georg Ebersbach
Journal:  J Neural Transm (Vienna)       Date:  2016-11-15       Impact factor: 3.575

2.  Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson's disease.

Authors:  Fabrizio Stocchi; Patrizio Sale; Ana F R Kleiner; Miriam Casali; Veronica Cimolin; Francesca de Pandis; Giorgio Albertini; Manuela Galli
Journal:  Int J Rehabil Res       Date:  2015-09       Impact factor: 1.479

3.  Beneficial Effect of Foot Plantar Stimulation in Gait Parameters in Individuals with Parkinson's Disease.

Authors:  Lorenzo Brognara; Emmanuel Navarro-Flores; Lorenzo Iachemet; Nuria Serra-Catalá; Omar Cauli
Journal:  Brain Sci       Date:  2020-01-27

Review 4.  Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for Rehabilitation.

Authors:  Davide Ferrazzoli; Adrian Carter; Fatma S Ustun; Grazia Palamara; Paola Ortelli; Roberto Maestri; Murat Yücel; Giuseppe Frazzitta
Journal:  Front Behav Neurosci       Date:  2016-06-14       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.